Jane E. Findlay
150 Stamford Street
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Blocking the Dkk1-LRP6 interaction prevents acute amyloid-β-driven cognitive impairment.
Journal: Cellular signalling
Published: January 24, 2025
Ang-(1-7) and ET-1 Interplay Through Mas and ETB Receptor Interaction Defines a Novel Vasoprotective Mechanism.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: December 05, 2024
cAMP-phosphodiesterase 4D7 (PDE4D7) forms a cAMP signalosome complex with DHX9 and is implicated in prostate cancer progression.
Journal: Molecular oncology
Published: April 22, 2023
CMYA5 is a novel interaction partner of FHL2 in cardiac myocytes.
Journal: The FEBS journal
Published: June 23, 2021
Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
Journal: The Journal of biological chemistry
Published: September 17, 2019
Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 19, 2019
Phosphorylation of PDE4A5 by MAPKAPK2 attenuates fibrin degradation via p75 signalling.
Journal: Journal of biochemistry
Published: October 22, 2018
Eps8 controls Src- and FAK-dependent phenotypes in squamous carcinoma cells.
Journal: Journal of cell science
Published: November 01, 2014
Targeted disruption of the heat shock protein 20-phosphodiesterase 4D (PDE4D) interaction protects against pathological cardiac remodelling in a mouse model of hypertrophy.
Journal: FEBS open bio
Published: June 20, 2014
Compaction of a prokaryotic signal-anchor transmembrane domain begins within the ribosome tunnel and is stabilized by SRP during targeting.
Journal: Journal of molecular biology
Published: January 27, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026